The team spread across the continent received a joint investment of $7.2 million from a medical research charity to develop new drugs for the two deadly diseases. The initiative aims to address a need for innovative tools to combat malaria and TB, which collectively claim nearly one million lives in Africa annually. Approximately 600,000 and 400 deaths are attributed to malaria TB respectively.